MediciNova Inc MNOV:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/16/24 EDT
1.43quote price arrow down-0.06 (-4.03%)
Volume
12,108
52 week range
1.26 - 2.66
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.43
  • 52 Week High2.66
  • 52 Week High Date07/11/23
  • 52 Week Low1.26
  • 52 Week Low Date02/27/24

Key Stats

  • Market Cap70.136M
  • Shares Out49.05M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta0.73
  • YTD % Change-0.67

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.43
  • 52 Week High2.66
  • 52 Week High Date07/11/23
  • 52 Week Low1.26
  • 52 Week Low Date02/27/24
  • Market Cap70.136M
  • Shares Out49.05M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta0.73
  • YTD % Change-0.67

RATIOS/PROFITABILITY

  • EPS (TTM)-0.17
  • P/E (TTM)-8.34
  • Fwd P/E (NTM)-6.22
  • EBITDA (TTM)-10.051M
  • ROE (TTM)-13.18%
  • Revenue (TTM)1.00M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-840.85%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/08/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On MediciNova Inc

 

Profile

MORE
MediciNova, Inc. is a biopharmaceutical company. The Company is focused on developing therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States market. It is focused on its development activities on MN-166 (ibudilast) for neurological and other disorders, such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy...
Yuichi Iwaki M.D., Ph.D.
President, Chief Executive Officer, Director
Jason Kruger
Chief Financial Officer
Address
SUITE 650, 4275 EXECUTIVE SQUARE
La Jolla, CA
92037
United States

Top Peers

SYMBOLLASTCHG%CHG
RLYB
Rallybio Corp
1.86-0.05-2.62%
CVM
CEL-SCI Corp
1.40-0.04-2.78%
BTAI
BioXcel Therapeutics Inc
2.09+0.03+1.46%
CGTX
Cognition Therapeutics Inc
1.94-0.01-0.51%
TPST
Tempest Therapeutics Inc
3.22-0.16-4.73%